STUDIES OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE GENES IN INFANTS AND CHILDREN MANIFESTING PREMATURE PUBARCHE AND INCREASED ADRENOCORTICOTROPIN-STIMULATED DELTA(5)-STEROID LEVELS

Citation
H. Sakkalalkaddour et al., STUDIES OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE GENES IN INFANTS AND CHILDREN MANIFESTING PREMATURE PUBARCHE AND INCREASED ADRENOCORTICOTROPIN-STIMULATED DELTA(5)-STEROID LEVELS, The Journal of clinical endocrinology and metabolism, 81(11), 1996, pp. 3961-3965
Citations number
25
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
81
Issue
11
Year of publication
1996
Pages
3961 - 3965
Database
ISI
SICI code
0021-972X(1996)81:11<3961:SO3DGI>2.0.ZU;2-M
Abstract
Classic 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) deficiency co ngenital adrenal hyperplasia (CAH) results from a mutation in the type II 3 beta HSD gene encoding adrenal and gonadal 3 beta HSD. We invest igated the type II and type I 3 beta HSD gene sequences in 15 infants and children with premature pubarche (PP; mean/range of age at PP, 4/0 .08-9 yr) and elevated ACTH-stimulated Delta(5) precursor steroid leve ls. Compared to Tanner I control subjects of similar age, ACTH-stimula ted hormonal levels were at 2.3-10.7 SD for 17-hydroxypregnenolone (De lta(5)-17P) in all PP subjects, at 2.2-17 SD for dehydroepiandrosteron e (DHEA) and 2.4-5.6 SD for the Delta(5)-17P/cortisol(F) ratio in all PP subjects except 1 infant, and at 2.3-10 SD for the DHEA/androstened ione (Delta(4)-A) ratio in 8 PP subjects. Compared to Tanner II normal children, the hormonal levels were at 3-8 SD for Delta(5)-17P in all 13 PP children, at 2.3-4.7 so for the Delta(5)-17P/F ratio in 6 PP chi ldren, and at 2.3-6.5 SD for DHEA and 3.5-9 SD for the DHEA/Delta(4)-A ratio in 7 PP children. Type II 3 beta HSD gene sequences, including regions of a putative promoter, all exons (I, II, III, and IV), and ex on-intron boundaries, were normal in all subjects. Sequences of the ty pe I 3 beta HSD gene encoding extraadrenal and extragonadal 3 beta HSD were normal in the 6 patients tested. The ACTH-stimulated Delta(5)-17 P levels and Delta(5)-17P/F ratios in the PP children without type II 3 beta HSD gene mutation were exceedingly lower than the respective re ported hormonal data for children with 3 beta HSD deficiency CAH with proven type II 3 beta HSD gene mutation. The ACTH-stimulated DHEA leve ls and DHEA/Delta(4)-A ratios were not exceedingly different between t he children with and without type II 3 beta HSD gene mutation. These f indings suggest that the degree of ACTH-stimulated Delta(5) precursor steroid abnormality, such as Delta(5)-17P levels up to 10 SD above the normal mean level found in our PP patients, is not caused by a mild v ariant of 3 beta HSD deficiency CAH resulting from type II or type I 3 beta HSD gene mutation. The hormonal criterion for ACTH-stimulated De lta(5)-17P levels in patients with mild variant 3 beta HSD deficiency, therefore, is predicted to be higher than 10 SD above the normal mean value.